University of California, San Francisco
San Francisco, California, United States
David R. Raleigh, MD, PhD, is an Associate Professor and Physician Scientist in the Departments of Radiation Oncology, Neurological Surgery, and Pathology at the University of California San Francisco (UCSF). His lab is focused on understanding the genomic, biochemical, and cellular drivers of tumor heterogeneity and evolution, and his research integrates human samples with diverse evolutionary and preclinical models to study cancer predisposition, tumorigenesis, and treatment resistance. Dr. Raleigh is the Robert and Ruth Halperin Endowed Chair in Meningioma Research, and the Director of the Preclinical Therapeutics Core in the UCSF Brain Tumor Center. In addition to illuminating how tumors develop and respond to treatment, his research has shed light on fundamental signaling mechanisms through the Hedgehog pathway and neurofibromatosis tumor suppressors that are relevant to mammalian development. As a practicing physician, Dr. Raleigh treats adult and pediatric patients with nervous system tumors using radiotherapy and radiosurgery.
